Flagship Pioneering
| Company type | Private |
|---|---|
| Industry | Venture capital, Biotechnology, Life sciences, Health, Sustainability |
| Predecessor | NewcoGen |
| Founded | 1999 in Cambridge, Massachusetts, United States |
| Founder | Noubar Afeyan, Ed Kania |
| Headquarters | Cambridge , United States |
Area served | Worldwide |
Key people | Noubar Afeyan (Co-Founder and CEO) |
| Products | Venture capital investments in biotech startups (e.g., Moderna, Indigo Agriculture, Inari Agriculture, Novomer) |
| Website | flagshippioneering |
Flagship Pioneering is a venture capital firm headquartered in Cambridge, Massachusetts, specializing in investments within the biotechnology, life sciences, health, and sustainability industries. Established in 1999, the firm is involved in both financing and nurturing startup companies. Its portfolio features prominent enterprises such as Moderna, Indigo Agriculture, Inari Agriculture, and Novomer. Under the leadership of Co-Founder and CEO Noubar Afeyan, Flagship has secured substantial funding to drive innovation across biotech and associated fields.
History
The company was originally created in Cambridge in 1999 by Noubar Afeyan and Ed Kania under the name NewcoGen. It later underwent rebranding phases from Flagship Ventures to its current name, Flagship Pioneering, in 2016. Initial management included partners affiliated with the venture capital firm Morgan Holland.
Flagship established Moderna in 2010, a company dedicated to drug development and vaccine technologies utilizing messenger RNA (mRNA). Moderna became widely recognized for its COVID-19 vaccine.
In 2013, Flagship co-founded Editas Medicine, focusing on therapeutic applications of CRISPR gene editing technology, particularly targeting the Cas9 enzyme. The company was founded by notable scientists including Feng Zhang, Jennifer Doudna, George Church, J. Keith Joung, and David R. Liu. Jennifer Doudna, awarded the 2020 Nobel Prize in Chemistry for her CRISPR research, departed from Editas in 2014 amid intellectual property conflicts.